Vodobatinib for Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia Resistant or Intolerant to Multiple Lines of Previous Therapy: an Open-Label, Multicentre, Phase 1/2 TrialJorge E Cortes,Dong-Wook Kim,Tapan Saikia,Navin Khattry,Krishnakumar Rathnam,Yesid Alvarado,Guy Hannah,Srinivas K Tantravahi,Jane F Apperley,Aude Charbonnier,Valentin García-Gutiérrez,Alessandro Lucchesi,Delia Dima,Árpád Illés,Viola M Popov,Elisabetta Abruzzese,Arijit Nag,Shashikant Apte,Talha Badar, Siu-Long YaoThe Lancet Haematology(2025)引用 0|浏览0AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要